That's what I meant really.Especially as there is not even a generally accepted definition of when the seasons start and finish.
That's what I meant really.Especially as there is not even a generally accepted definition of when the seasons start and finish.
Back to normal is perception as much as what's happening. Things will be back to normal in late spring and early summer, but that's because people will have had enough, as opposed to virus transmission or even deaths and hospitalisations. So it's quite possible that you might have what many on here regard as scarily high deaths going on in the background, but life is more like say tier 1 is now, but for most of the country.
I'm way down the pecking order just!! Shall see though the big 50 awaits this summer.
Last bit's wrong (was posted in late Jan). The earliest the UK can get 'close to' or 'approach' herd immunity is end July (all adults vaccinated).You're right [@lane ] . . There will be restrictions through till the summer, so it'd be disingenuous for the PM to say otherwise.
Reiterate: All those involved in procurement, distribution, storage (at the various levels across the nation), management and delivery (into arms) deserve massive plaudits. This is not a short race though; but by the end of spring the UK should be close to herd immunity . . . . Internal transmission will diminish and infections brought in from abroad will not gain a foothold and should be much easier to control, with minimal loss of life or serious illness.
Who might we look to when a 'a bit more oomph' is needed?I am a JVT fan but thought his reinforcement of the above message in the TV briefing a few nights back was not hard hitting enough when delivered in a softly patronising tone. Ditto Hancock who I have not been particularly critical of thus far. Needs a bit more ooomph the get the 'it's not all over' message across imo.
USA FDA approved Janssen/J&J one dose vaccine. 85% protective even in South Africa, says https://www.thejournal.ie/johnson-j...cine-cleared-by-us-officials-5367928-Feb2021/
USA FDA approved Janssen/J&J one dose vaccine. 85% protective even in South Africa, says [an Irish newspaper]
Thank you for that 'heads up'. Here is the J&J Announcement of Clinical Trial Results (29 Jan) which (assume) reflects the results shared with the FDA. I don't know if similar definitions were used in the Pfizer, Oxford-AZ and/or Moderna clinical trails.Read carefully. The 85% is against severe illness and death; efficacy is normally quoted against all symptomatic disease.
None of which is to say there's anything wrong with the J&J vaccine, far from it, just to be cautious of what's in press releases.
I blame the chancellor and shadow chancellor for giving such bland interviews this morning!ITV News full of dread over 6 cases of Brazil variant in the UK... no evidence, just whipping up tension as they can't report whether the Brazil variant will or won't adversely affect vaccinated population... must be a slow news day.
Yep, that's the difference between efficacy and protectiveness. Sorry if it's not been covered in this thread before and thank you for filling in the gap.Read carefully.
The 85% is against severe illness and death; efficacy is normally quoted against all symptomatic disease.
Read carefully.
The 85% is against severe illness and death; efficacy is normally quoted against all symptomatic disease.
The J&J vaccine is very similar to the AZ vaccine, and has similar efficacy for one shot too, for time periods where comparisons are available. AZ did not do a phase III trial with one shot, so can't claim efficacy for that.
None of which is to say there's anything wrong with the J&J vaccine, far from it, just to be cautious of what's in press releases.
We don't know what difference on long term efficacy the single shot strategy has, but I'd be happier with a two shot, given the limited data we have. I think J&J are also doing a two shot study.
Interesting quote you have written there. The study you quoted doesn't actually say that. It says this........
"One dose was 85% protective against the most severe Covid-19 illness, in a massive study that spanned three continents — protection that remained strong even in countries such as South Africa, where the variants of most concern are spreading."